Virginia Retirement Systems’s Soleno Therapeutics SLNO Stock Holding History

Virginia Retirement Systems’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-6,100	Closed	-$204K	–	1361
2026 Q1	$204K	Sell	6,100 -10,000	-62%	-$392K	﹤0.01%	902
2025 Q4	$745K	Sell	16,100 -1,600	-9%	-$87.7K	﹤0.01%	672
2025 Q3	$1.2M	Buy	17,700 +4,800	+37%	+$356K	0.01%	553
2025 Q2	$1.08M	Buy	+12,900	New	+$966K	0.01%	554

Virginia Retirement Systems's SLNO Position: Q2 2026 in Review

Virginia Retirement Systems sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 6,100 shares — an estimated $204K sold.

Virginia Retirement Systems first reported a position in SLNO in Q2 2025 and held it in 4 quarters. The position peaked at $1.2M in Q3 2025. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

Virginia Retirement Systems reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
Virginia Retirement Systems sold 6,100 Soleno Therapeutics shares in Q2 2026, an estimated $204K.
Virginia Retirement Systems first reported a position in Soleno Therapeutics in Q2 2025 and held it in 4 quarters.
Virginia Retirement Systems's Soleno Therapeutics position peaked at $1.2M in Q3 2025.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on Virginia Retirement Systems's 13F filing for Q2 2026, filed 25 Aug 2026.